notch receptor 1
Last updated 8 May 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The NOTCH1 gene provides instructions for making a protein called Notch1, a member of the Notch family of receptors. Receptor proteins have specific sites into which certain other proteins, called ligands, fit like keys into locks. Attachment of a ligand to the Notch1 receptor sends signals that are important for normal development of many tissues throughout the body, both before birth and after. Notch1 signaling helps determine the specialization of cells into certain cell types that perform particular functions in the body (cell fate determination). It also plays a role in cell growth and division (proliferation), maturation (differentiation), and self-destruction (apoptosis).
Video picks for GenesVideo library
Normal function
The NOTCH1 gene provides instructions for making a protein called Notch1, a member of the Notch family of receptors. Receptor proteins have specific sites into which certain other proteins, called ligands, fit like keys into locks. Attachment of a ligand to the Notch1 receptor sends signals that are important for normal development of many tissues throughout the body, both before birth and after. Notch1 signaling helps determine the specialization of cells into certain cell types that perform particular functions in the body (cell fate determination). It also plays a role in cell growth and division (proliferation), maturation (differentiation), and self-destruction (apoptosis).
The protein produced from the NOTCH1 gene has such diverse functions that the gene is considered both an oncogene and a tumour suppressor. Oncogenes typically promote cell proliferation or survival, and when mutated, they have the potential to cause normal cells to become cancerous. In contrast, tumour suppressors keep cells from growing and dividing too fast or in an uncontrolled way, preventing the development of cancer; mutations that impair tumour suppressors can lead to cancer development.
Conditions referring to this gene or chromosome
Other names
AOS5
AOVD1
hN1
neurogenic locus notch homolog protein 1
neurogenic locus notch homolog protein 1 preproprotein
Notch homolog 1, translocation-associated
TAN1
translocation-associated notch protein TAN-1
Patient picks for Genes

Medicine
Olmesartan - an angiotensin receptor blocker
Take olmesartan once each day. You can take your doses either before or after a meal. Keep your regular appointments with your doctor to have your blood pressure measured. Some painkillers can interfere with olmesartan and increase the risk of side-effects, so ask a pharmacist for advice before you buy any medicines 'over the counter'.
by Michael Stewart, MRPharmS

Medicine
Losartan - an angiotensin receptor blocker
Take losartan once each day. You can take your doses either before or after a meal. Any side-effects are usually mild, and can include feeling dizzy or light-headed. Some painkillers can interfere with losartan and increase the risk of side-effects, so ask a pharmacist for advice before you buy any medicines 'over the counter'. Do not drink grapefruit juice whilst taking losartan. It can interact with the medicine and alter its effect.
by Michael Stewart, MRPharmS

Medicine
Telmisartan - an angiotensin receptor blocker
The usual dose is one tablet daily. You can take telmisartan before or after meals. Side-effects are usually mild. They include feeling dizzy and stomach upset. Keep your regular appointments with your doctor to have your blood pressure measured. Some painkillers interfere with telmisartan, so ask your pharmacist for advice before you buy any medicines.
by Michael Stewart, MRPharmS

Medicine
Valsartan - an angiotensin receptor blocker
You can take valsartan either before or after a meal. Any side-effects are usually mild. The most common side-effect is dizziness. Some painkillers may interfere with valsartan and increase the risk of side-effects, so ask a pharmacist for advice before you buy any medicines.
by Michael Stewart, MRPharmS

Medicine
Candesartan - an angiotensin receptor blocker
Take candesartan once each day. You can take the tablets either before or after a meal. Any side-effects are usually mild. They include headache and feeling dizzy. Some painkillers may interfere with candesartan and increase the risk of side-effects, so ask a pharmacist for advice before you buy any medicines.
by Michael Stewart, MRPharmS

Medicine
Irbesartan - an angiotensin receptor blocker
Take irbesartan once each day. You can take the tablets before or after meals. Side-effects are usually mild. They include feeling dizzy and mild stomach upset. Keep your regular appointments with your doctor to have your blood pressure measured. Some painkillers interfere with irbesartan, so ask a pharmacist for advice before you buy any medicines.
by Michael Stewart, MRPharmS
Related patient information and medicines

Patient information leaflet
Loss of taste and smell
... a pairOur sense of taste is powered by taste receptors found in the taste buds on our tongues and also in our mouths. Smell, like taste, is a chemical sense detected by sensory cells called chemoreceptors. When an odour stimulates the chemoreceptors in the nose that detect smell, they pass on electrical impulses to the brain. This happens in.

Patient information leaflet
Breast cancer
These are called carcinoma in situ (or non-invasive breast cancer), as no cancer cells have grown out from their original site. Ductal carcinoma in situ (DCIS) is the most common type of non-invasive breast cancer and about 1 in 5 new breast cancer cases will be DCIS. A carcinoma in situ is easier to treat and has a better outlook than an invasive.

Patient information leaflet
Myasthenia gravis
Understanding muscle Each muscle is supplied by a nerve which splits into smaller nerves as they spread along the muscle fibres. There is a tiny gap between the ends of the ner... Myasthenia gravis Myasthenia gravis The brain sends messages down the nerves to the muscles it wants to tighten (contract). What causes myasthenia gravis. Myasthenia.

Patient information leaflet
Nausea medicine
Various medicines are available to treat nausea. Listed below are some of the more commonly prescribed medicines: Cinnarizine Cinnarizine tablets , cyclizine Cyclizine for sickness , promethazine Promethazine - these medicines belong to a group of medicines called antihistamines Antihistamines. It is thought that antihistamines block histamine 1.

Patient information leaflet
Vaginal dryness
You may... This may make the area also look slightly different to how it was before the menopause. Vaginal dryness is a common symptom of the menopause; after the menopause at least half of women have some symptoms related to vaginal dryness and thinning of the vaginal tissue. You are also more likely to experience symptoms as more years pass.

Patient information leaflet
Can I take Bisoprolol and Trimbow together?
It also makes the formoterol in the Trimbow inhaler less effective at opening your airways. Why this happens Bisoprolol is a 'beta-blocker' and formoterol (in Trimbow) is a 'beta-agonist'. They compete for the same receptors in the lungs. Disclaimer This information is for general educational purposes only and should not be relied upon as a.
Further reading and references
- notch receptor 1; MedlinePlus, National Library of Medicine.
- Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Trevino L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011 Aug 26;333(6046):1154-7. doi: 10.1126/science.1206923. Epub 2011 Jul 28.
- Arruga F, Gizdic B, Serra S, Vaisitti T, Ciardullo C, Coscia M, Laurenti L, D'Arena G, Jaksic O, Inghirami G, Rossi D, Gaidano G, Deaglio S. Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. Leukemia. 2014 May;28(5):1060-70. doi: 10.1038/leu.2013.319. Epub 2013 Oct 30.
- Dotto GP. Notch tumor suppressor function. Oncogene. 2008 Sep 1;27(38):5115-23. doi: 10.1038/onc.2008.225.
- Lobry C, Oh P, Aifantis I. Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think. J Exp Med. 2011 Sep 26;208(10):1931-5. doi: 10.1084/jem.20111855.
- Loyo M, Li RJ, Bettegowda C, Pickering CR, Frederick MJ, Myers JN, Agrawal N. Lessons learned from next-generation sequencing in head and neck cancer. Head Neck. 2013 Mar;35(3):454-63. doi: 10.1002/hed.23100. Epub 2012 Aug 21.
- McKellar SH, Tester DJ, Yagubyan M, Majumdar R, Ackerman MJ, Sundt TM 3rd. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2007 Aug;134(2):290-6. doi: 10.1016/j.jtcvs.2007.02.041.
- Southgate L, Sukalo M, Karountzos ASV, Taylor EJ, Collinson CS, Ruddy D, Snape KM, Dallapiccola B, Tolmie JL, Joss S, Brancati F, Digilio MC, Graul-Neumann LM, Salviati L, Coerdt W, Jacquemin E, Wuyts W, Zenker M, Machado RD, Trembath RC. Haploinsufficiency of the NOTCH1 Receptor as a Cause of Adams-Oliver Syndrome With Variable Cardiac Anomalies. Circ Cardiovasc Genet. 2015 Aug;8(4):572-581. doi: 10.1161/CIRCGENETICS.115.001086. Epub 2015 May 11.
- Stittrich AB, Lehman A, Bodian DL, Ashworth J, Zong Z, Li H, Lam P, Khromykh A, Iyer RK, Vockley JG, Baveja R, Silva ES, Dixon J, Leon EL, Solomon BD, Glusman G, Niederhuber JE, Roach JC, Patel MS. Mutations in NOTCH1 cause Adams-Oliver syndrome. Am J Hum Genet. 2014 Sep 4;95(3):275-84. doi: 10.1016/j.ajhg.2014.07.011. Epub 2014 Aug 14.
- Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004 Oct 8;306(5694):269-71. doi: 10.1126/science.1102160.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

